Byrna Technologies Inc. (BYRN) shares ended the last trading session 18% higher at $31.35. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 17.4% gain over the past four weeks.The stock is benefitting from the record-setting revenue expectation announced during the company’s 2Q25 preliminary results. These record quarterly revenues mark a 41% y/y increase.This company is expected to post quarterly earnings of $0.04 ...

Media & entertainment stock Warner Bros Discovery Inc (NASDAQ:WBD) was last seen up 10.1% at $10.81, after the company announced it will split into two publicly traded companies by next year. CEO David Zaslav will head the streaming and studios company, which will contain HBO Max, while CFO Gunnar Wiedenfels will become CEO of the global networks business, which includes CNN, TNT Sports, and Discovery.Today's pop has Warner Bros stock breaking above recent pressure at $10, trading at its highest level since ...

Shares of Alvotech (ALVO) have gained 10.1% over the past four weeks to close the last trading session at $10.66, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $18.40 indicates a potential upside of 72.6%.The average comprises five short-term price targets ranging from a low of $14 to a high of $28, with a standard deviation of $5.73. While the lowest estimate indicates an inc ...

Shares of Apogee Therapeutics Inc. (APGE) have gained 9.9% over the past four weeks to close the last trading session at $40.98, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $93.88 indicates a potential upside of 129.1%.The average comprises eight short-term price targets ranging from a low of $78 to a high of $116, with a standard deviation of $11.05. While the lowest estima ...

Shares of Concentra Group (CON) have gained 2.9% over the past four weeks to close the last trading session at $22.03, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $28 indicates a potential upside of 27.1%.The average comprises eight short-term price targets ranging from a low of $25 to a high of $30, with a standard deviation of $1.85. While the lowest estimate indicates an ...

Shares of BILL Holdings (BILL) have gained 2% over the past four weeks to close the last trading session at $45.62, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $66.75 indicates a potential upside of 46.3%.The average comprises 24 short-term price targets ranging from a low of $40 to a high of $120, with a standard deviation of $20.19. While the lowest estimate indicates a de ...

Shares of Birkenstock (BIRK) have gained 4.1% over the past four weeks to close the last trading session at $54.76, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $68.88 indicates a potential upside of 25.8%.The average comprises 17 short-term price targets ranging from a low of $57 to a high of $81, with a standard deviation of $7.34. While the lowest estimate indicates an inc ...

Shares of Monte Rosa Therapeutics (GLUE) have gained 22.5% over the past four weeks to close the last trading session at $5.01, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $16.14 indicates a potential upside of 222.2%.The mean estimate comprises seven short-term price targets with a standard deviation of $3.98. While the lowest estimate of $10 indicates a 99.6% increase from ...

Shares of Phathom Pharmaceuticals, Inc. (PHAT) have gained 184.1% over the past four weeks to close the last trading session at $8.92, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $18.50 indicates a potential upside of 107.4%.The mean estimate comprises eight short-term price targets with a standard deviation of $8.09. While the lowest estimate of $5 indicates a 44% decline f ...

The RealReal (REAL) closed the last trading session at $5.71, gaining 13.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $10.10 indicates a 76.9% upside potential.The mean estimate comprises five short-term price targets with a standard deviation of $3.09. While the lowest estimate of $7 indicates a 22.6% increase from the current price level, the most optimistic analyst expects ...